期刊文献+

EGF与外阴癌发生发展的关系 被引量:4

To Explore the Relationship Between the Expression of EGF and the Development of Vulvar Carcinoma
暂未订购
导出
摘要 目的:通过检测表皮生长因子(EGF)在正常外阴皮肤、外阴上皮内瘤变(VIN)和外阴鳞状细胞癌(VSCC)中的表达,探讨其在外阴癌变中的作用。方法:应用免疫组化SP法进行检测。EGF的表达与外阴肿瘤的临床病理特征相比较。结果:正常外阴组织、低级别VINs、高级别VINs、外阴癌中EGF蛋白阳性表达率分别为0(0/20)、18.2%(2/11)、82.8%(9/11)、100%(60/60),P<0.05。在高、中、低分化的浸润性外阴癌中,EGF的细胞阳性表达率分别为36.2%、42.7%、47.1%,P>0.05。有淋巴结转移者EGF蛋白阳性表达率为30.2%明显低于无淋巴结转移者的49.8%。结论:EGF蛋白的异常表达在外阴癌的发生发展中起着重要的作用,而且可为外阴癌的预后提供重要的信息。 Objective:To study the role of epidermal growth factor(EGF)in vulvar carcinogenesis by determining the expression in normal vulvas and vulvar intraepithelial neoplasia(VIN)and vulvar squamous cell carcinomas(VSCC).Methods:The immunohistochemistry SP method was used.The expressions of EGF were analyzed with clinical-pathologic featuers of vulvar tumors.Results:The positive rates of expression of FHIT protein in the squamous epithelium of normal vulvas,VINI-II,VINIII and noninvasive carcinoma and invasive vulvar carcinoma were 0(0/20)、18.2%(2/11)、82.8%(9/11)、100%(60/60),respectively(P0.05)。The rate of the EGF protein expression in the invasive vulva carcinoma with lymphnode metastasis(30.2%)was lower than that without lymphnode metastasis(49.8%).Conclusion:Abnormal EGF expression may play an important role in the progression of vulvar carcinoma.Furthermore,the expression of EGF may provide important information for the prognosis of vulva carcinoma.
出处 《中外妇儿健康(学术版)》 2011年第4期13-14,共2页
关键词 表皮生长因子 外阴上皮内瘤变 外阴癌 Epidermal growth factor VIN Vulvar carcinomas
  • 相关文献

参考文献15

  • 1张国新,赵志泉,林秀文.EGF/PI3K信号传导调控骨桥蛋白在肝癌HepG2细胞中的表达[J].中华医学杂志,2003,83(22):1980-1983. 被引量:6
  • 2李孟达,罗焕〓.外阴及阴道肿瘤的诊治[M]辽宁科学技术出版社,1997.
  • 3S. Hoffmann,S. Gl?ser,A. Wunderlich,S. Lingelbach,C. Dietrich,A. Burchert,H. Müller,M. Rothmund,A. Zielke.Targeting the EGF/VEGF-R system by tyrosine-kinase inhibitors—a novel antiproliferative/antiangiogenic strategy in thyroid cancer[J]. Langenbeck’s Archives of Surgery . 2006 (6)
  • 4Francesco Boccardo,Gian Luigi Lunardi,Anna Rita Petti,Alessandra Rubagotti.Enterolactone in Breast Cyst Fluid: Correlation with EGF and Breast Cancer Risk[J]. Breast Cancer Research and Treatment . 2003 (1)
  • 5X. Wu,Yan Xin,Jiaiei Yao,Kazuhisa Hasui,Shin-ichiro Tsuyama,Suguru Yonezawa,F. Murata.Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study[J]. Medical Electron Microscopy . 2001 (3)
  • 6Grudinkin PS,Zenin VV,Kropotov AV, et al.EGF-induced apoptosis in A431 cells is dependent on STAT1, but not on STAT3. European Journal of Cell Biology . 2007
  • 7M Boccellino,G Giuberti,L Quagliuolo.Apoptosis induced by interferon-α and antagonized by EGF is regulated by caspase-3-mediated cleavage of gelsolin in human epidermoid cancer cells. Journal of Cellular Physiology . 2004
  • 8Bianco R,Gelardi T,Damiano V,et al.Rational bases for the development of EGFR inhibitors for cancer treatment. International Journal of Biochemistry Cell Biology The . 2007
  • 9Levi E,,Mohammad R,,Kodali U, et al.EGF-receptor related protein causes cell cycle arrest and induces apoptosis of colon cancer cells in vitro and in vivo. Anticancer Research . 2004
  • 10L Bonaccorsi,V Carloni,M Muratori,L Formigli,S Zecchi,G Forti,E Baldi.EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR). International Journal of Cancer . 2004

二级参考文献13

  • 1Weber GF, Ashkar S, Cantor H, et al. Receptor -ligand interaction between CD44 and osteopontin(Eta-1). Science, 1996, 271: 509-512.
  • 2Oates AJ, Barraclough R, Rudland PS, et al. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene, 1996, 13: 97-104.
  • 3Urquidi V, Sloan D, Kawai K, et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res, 2002, 8: 61-74.
  • 4Weber GF. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta, 2001, 1552: 61-85.
  • 5Liu D, Aguirre Ghiso J, Estrada Y, et al. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell, 2002, 1:405-406.
  • 6Ito Y, Takeda T, Sakon M, et al. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma. Br J Cancer, 2001, 84:1377-1383.
  • 7Chambers AF, Behrend EI, Wilson SM, et al. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells. Anticancer Res, 1992, 12:43-48.
  • 8Behrend EI, Craig AM, Wilson SM, et al. Reduced malignancy of ras-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res, 1994, 54: 832-837.
  • 9Gotoh M, Sakamoto M, Kanetaka K, et al. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int, 2002, 52:19-24.
  • 10Tuck AB, Hota C, Wilson SM, et al. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways. Oncogene, 2003, 22:1198-1205.

共引文献5

同被引文献57

引证文献4

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部